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Abstract
Background:  Protein-protein, protein-DNA and protein-RNA interactions are of central
importance in biological systems. Quadrapole Time-of-flight (Q-TOF) mass spectrometry is a
sensitive, promising tool for studying these interactions. Combining this technique with chemical
crosslinking, it is possible to identify the sites of interactions within these complexes. Due to the
complexities of the mass spectrometric data of crosslinked proteins, new software is required to
analyze the resulting products of these studies.
Result: We designed a Cross-Linked Peptide Mapping (CLPM) algorithm which takes advantage of
all of the information available in the experiment including the amino acid sequence from each
protein, the identity of the crosslinker, the identity of the digesting enzyme, the level of missed
cleavage, and possible chemical modifications. The algorithm does in silico digestion and crosslinking,
calculates all possible mass values and matches the theoretical data to the actual experimental data
provided by the mass spectrometry analysis to identify the crosslinked peptides.
Conclusion: Identifying peptides by their masses can be an efficient starting point for direct
sequence confirmation. The CLPM algorithm provides a powerful tool in identifying these potential
interaction sites in combination with chemical crosslinking and mass spectrometry. Through this
cost-effective approach, subsequent efforts can quickly focus attention on investigating these
specific interaction sites.
Background
Proteins function through complex interactions with
other proteins, DNA and RNA and these interactions play
a central role in all biological processes. The study of these
interactions is an essential requirement to understanding
these processes [1-4]. Since errors in these interactions can
manifest in disease, potential targets for therapeutic inter-
vention may be identified through these efforts [2,5-7].
A number of approaches have been developed to analyze
these associations. These include older, time-consuming,
relatively low-throughput methods such as "two-hybrid"
and more established methods such as X-ray crystallogra-
phy and Nuclear Magnetic Resonance (NMR) spectros-
copy. These tactics have provided insight into the spatial
and topological organization of proteins and protein
complexes. However, NMR spectroscopy needs large
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quantities of purified protein in specific solvents, whereas
X-ray studies require that the protein be crystallizable [4].
A more recent strategy based on immuno-affinity, purifies
the non-covalently-interacting complex and sequentially
analyzes it using mass spectrometry. While this has been
proven to be a powerful method for identifying the com-
plex of proteins [8-12], it doesn't provide specific infor-
mation about the interacting surfaces. However, because
of its ultra-sensitive and high-throughput features, mass
spectrometry has become the method of choice in the
study of proteins and protein complexes [1,2]. Among the
several kinds of mass spectrometry, ElectroSpray Ioniza-
tion (ESI) and Matrix-Assisted Laser Desorption Ioniza-
tion (MALDI) are the most widely used [13-17].
In order to identify the interacting sites of these com-
plexes, several labs have reported that chemical crosslink-
ing helps to covalently stabilize them. These complexes
may then be subjected to gel electrophoresis (to separate
crosslinked species) and enzymatic digestion (to yield
crosslinked and uncrosslinked peptides). The resulting
peptides are then analyzed by mass spectrometry [3,4,16-
21]. Chemical crosslinking is also used to study a protein's
three-dimensional structure by forming intra-molecular
crosslinks [3,22-24]. Unfortunately, the complexities of
the mass spectrum of the crosslinked species have been
exacerbated by the introduction of the crosslinker.
Some currently-available software such as MASCOT,
which identifies proteins from primary sequence data-
bases [25], and SALSA, which detects electrophile-
adducted peptides by pattern recognition [26], are ori-
ented towards analyzing uncrosslinked data. Sandia
National Laboratories provides a free, web-accessible soft-
ware package, Automated Spectrum Assignment Program
(ASAP) [27] for analyzing chemically-crosslinked protein
data from mass spectrometry. With ASAP, however, it is
impossible to calculate the cross-linking products from
peptides derived from more than one protein and the
maximum number of modifications is limited to four
[3,27]. For the analysis of protein-oligonucleotide interac-
tions, initiating the crosslinked complex by photochemi-
cal crosslinking [28-32] is most often used. Since a third
component is not introduced in this approach, the
crosslinking of the oligonucleotide remnant can be
treated as a type of modification and analyzed by a ver-
sion of MASCOT. Notwithstanding, there existed a need
for a more powerful and useful software package for the
analysis of crosslinked products.
To meet this need, we designed an algorithm, CLPM
(Cross-Linked Peptide Map), to map crosslinked peptides
derived from a crosslinking reaction of one or two pro-
teins whose sequences are known based on their masses.
The general strategy of this approach is shown in Figure 1.
The data used as input to this algorithm are the list of
mass/charge ratios and the charge of each precursor peak.
CLPM has been tested on samples of uncrosslinked pro-
teins, samples of chemically-crosslinked peptides and
samples of photochemically-crosslinked protein-DNA
and has produced valuable results.
Implementation
CLPM is accessible as an interactive web service though
the MidSouth Bioinformatics Center or as a downloada-
ble version upon request. The global structure of this pro-
gram is shown in Figure 2. Implemented as an object-
oriented program in C++, a specific design goal was to
allow easy modification and testing. The CLPM computa-
tional engine executes according to the workflow shown
in Figure 3.
The CLPM provides a simple, but flexible user interface
(Figure 4). For the specification of enzymes and crosslink-
ers, users can either select from a built-in list or define
their particular reagents. In the specification of possible
chemical modifications, many are available through a
built-in list; alternatively the user may define up to ten
custom modifications.
Since proteases may not be 100% effective, accommoda-
tion needs to be made for missed cleavages. A maximum
number of consecutive missed cleavages ranging from 0 to
5 can be specified in CLPM. CLPM assumes a monoiso-
tope mass measurement was performed.
General strategy of mass spectrometric analysis of protein- protein interactions Figure 1
General strategy of mass spectrometric analysis of 
protein-protein interactions. (A) Incubate the 
crosslinker with the target proteins to acquire crosslinked 
mixtures. (B) Purify the crosslinked species by SDS-PAGE 
and (C) extract spots and perform in-gel, protease digestion 
to yield a peptide pool, which includes crosslinked and 
uncrosslinked peptides. (D) The peptides are submitted to 
mass spectrometry to acquire either MS or MS/MS data. (E) 
Data are subsequently analyzed.
Data
analysis
A B
E D
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Because most of the widely-used enzymes digest proteins
at the C-terminus of restriction sites, the current version of
CLPM only supports these kinds of enzymes. To digest
proteins in silico, CLPM starts from the N-terminus of each
protein sequence and then assumes that the amino acid
following each cleavable site is a potential N-terminus of
a potential peptide. According to the missed-cleavage
level m, the C-terminus of each peptide is set to be a cleav-
able site with 0, 1... m missed cleavages. All peptides
derived from both proteins are stored in string vectors. For
a protein with n cleavable sites and an m missed-cleavage
level, there are (n+1)*(m+1)- [m*(m+1)/2] theoretical
uncrosslinked peptides generated. The mechanism of pro-
tein digestion is shown in Figure 5.
In CLPM, crosslinking is defined as occurring when both
arms of a crosslinker are linked to amino acids and this
crosslinked entity is treated as a peptide, not a modifica-
tion. The situation where only one arm of a crosslinker is
linked is treated as a modification to the peptide.
Crosslinking can occur between peptides (inter-peptide
crosslinking) or within a single peptide (intra-peptide
crosslinking). Furthermore, inter-peptide crosslinking can
be classified as intra-molecular crosslinking or inter-
molecular crosslinking; in the former case, the peptides
are from different proteins and, in the later case, the pep-
tides are from the same protein. To form intra-peptide
crosslinks, CLMP ensures that there are at least two linka-
ble sites within a peptide and the first two linkable sites
are used by the crosslinker. To form both types of inter-
peptide crosslinks, the first linkable site of each peptide is
reserved for the crosslinker. Trypsin, a common enzyme,
will not cleave at modified Lys and Arg sites, therefore,
peptides with modified C-terminus Lys or Arg are disre-
garded.
The mechanism of generating inter-peptide crosslinked
species is illustrated in Figure 6. CLMP generates a com-
plete peptides pool P where
P = {uncrosslinked peptides} U {intra-peptide
crosslinked peptides} U {intra-molecular crosslinked
peptides} U {inter-molecular crosslinked peptides}
The mass of an unmodified peptide is computed as the
mass of its amino acids adjusted as follows (water is
gained from hydrolytic digestion):
For uncrosslinked peptides:
mass = sum of masses of all amino acids + mass of water
For intra-peptide crosslinked peptides:
mass = sum of masses of all amino acids + mass of water
+ mass of crosslinker
For inter-peptide crosslinked peptides:
mass = sum of masses of all amino acids + (2 * mass of
water) + mass of crosslinker
Structure of CLPM Figure 2
Structure of CLPM. Three text files and other information 
are passed to the server CGI. The CGI reinterprets the data 
and writes a formatted data file readable by the CLPM com-
putational engine. Results are written to a file and passed 
back in html format.
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The workflow of CLPM Figure 3
The workflow of CLPM. Each step in CLPM is designed to 
be independent which makes debugging and future extension 
easier.
Acquire information from user
Digest proteins in-silico
Crosslink peptides in-silico
Calculate all possible theoretical mass values of
each crosslinked peptide, compare to 
calculated LC/MS data to find the matches.BMC Bioinformatics 2005, 6(Suppl 2):S9
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CLPM web interface Figure 4
CLPM web interface. The sequences and the mass spec data file in pkl format are imported from the user's local system. 
Users can select enzymes and crosslinkers from a predefined list or define their own custom versions. Users are allowed to 
select multiple modifications and define as many as ten additional modifications. Missed-cleavage level ranging from zero to five 
can be selected and the error tolerance is specified in parts per million.
CrosLinkPeptMapBMC Bioinformatics 2005, 6(Suppl 2):S9
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CLPM compares the mass of each peptide in P to each
observed mass from the mass spectrometric data. When a
match is found within the specified maximal mass differ-
ence, the search terminates and CLPM moves on to the
next peptide in P. If no match is found for an unmodified
peptide's mass value, CLPM will then consider its deriva-
tives with modifications. While a peptide may have mul-
tiple derivatives, the one encountered with a mass
difference which is the smallest among all its derivatives
and is within the specified maximum mass difference is
considered to be a match.
For a single peptide with j modifiable sites and xi possible
modifications at each site i, the number of theoretical
masses calculated is:
The mechanism to compute derivatives from a peptide is
shown in Figure 7.
Results
Assessment of CLPM by using an uncrosslinked sample
The MASCOT package was used as a benchmark to vali-
date the basic features of CLPM. Using liquid chromatog-
raphy (LC) tandem mass spectrometric (MS/MS) data
from bovine serum albumin (BSA), CLPM's ability to find
crosslinked peptides was compared to that of MASCOT;
while a simple test due to MASCOT's limited functional-
ity, this provided a basic initial validation.
Pretryptic uncrosslinked BSA (provided by Dr. Rick
Edmondson, NCTR Proteomics Center) 20 uL, 100 Pico
mole/uL was loaded through an inline HPLC Micromass
Q-TOF Micromass spectrometer (Waters, http://
www.waters.com) with a gradual increment of organic
solvent. Raw data were acquired under positive-ion mode
and processed by ProteinLynx 2.0 to generate a data file
(.pkl format); this was used as input to MASCOT and
CLPM. MASCOT required that carbamidomethylation of
Cys be a fixed modification, whereas CLPM allowed it to
be treated as a variable modification. In both programs,
acetylation of a protein's N-terminus, oxidation of Met,
and formation of pyroglutamic acid from N-terminal Glu
and Gln were treated as variable modifications. The
missed-cleavage level and the error tolerance were set to 2
and 100 ppm, respectively, in both programs. Only
monoisotopic values were calculated.
A total of 34 peptides were identified by MASCOT, while
45 peptide matches were found by CLPM. All 34 peptides
found by MASCOT were also identified by CLPM; the
other 11 peptides were uniquely found by CLPM. Results
are shown in Figure 8.
Assessment of CLPM by crosslinked samples
By peptide-peptide crosslinking
A short peptide – AYAGKAGAR – whose N-terminus has
been acetylated was chosen to crosslink to the same spe-
cies with the crosslinker Bis (sulfosuccinimidyl) suberate
(BS3) so that the result could be confirmed manually. This
peptide has been shown to produce good LC/MS/MS data
by Hansen, et al [26]. The peptide (synthesized by the LSU
Core Facility) and BS3 were dissolved in 15 mM PBS buffer
in a 2:1 mole-ratio and incubated at room temperature for
60 minutes, then quenched with glycine. Peptides were
() xi +
=
∏ 1
1 i
j
Mechanism of protein in silico digestion Figure 5
Mechanism of protein in silico digestion. To digest a 
protein (A) with four cleavable sites C1 to C4 with a missed-
cleavage level of 2, CLPM will generate peptides (B) with 
zero, one and two consecutively missed cleavage sites 
(shown in green). B located at the left side of the protein 
represents the N-terminus of the protein and Z represents 
the C-terminus.
K K R K BZ
C1 C2 C3 C4
A
C1C2
C1C2C3
C1C2C3C4
C2C3
C2C3C4
C2C3C4Z
C3C4
C3C4Z
C4Z BC1
BC1C2
BC1C2C3
B
Mechanism of forming inter-peptides crosslink in-silico Figure 6
Mechanism of forming inter-peptides crosslink in-sil-
ico. Given two proteins bz and BZ with 2 and 1 cleavable 
sites respectively and a missed-cleavage level of 1, CLPM will 
check whether or not there are crosslinking sites in each 
peptide. For those peptides with crosslinking sites (c and d in 
bz and C in BZ), CLPM will generate intra-molecule 
crosslinks (shown in blue) and inter-molecule crosslinks 
(shown in pink)
bz
c d BZ
C
Intra-molecular
crosslink
bc
bcd
cd
cdz
dz
BC
BCZ
CZ
Intra-molecular
crosslink
Inter-molecular
crosslinkBMC Bioinformatics 2005, 6(Suppl 2):S9
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extracted by reverse-phase ZipTip (Millipore) and eluted
into an elution buffer (50% Acetonitrile, 0.1%TFA). LC/
MS/MS data were acquired under positive-ion mode. The
peptide sequence AYAGKAGAR was used as input to
CLPM and peptide acetylation was selected as the only
modification.
Both crosslinked and uncrosslinked species were found by
CLPM (Figure 9). Surprisingly, the uncrosslinked specie
identified was the one without N-terminal acetylation.
The LC/MS spectrum is shown in Figure 9A. This "mis-
match" came about because (1) unacetylated peptide con-
taminates acetylated peptide since the latter is only
purified to 95% (see the MS spectrum in Figure 9A) and
(2) an effect of the "best-match" design of CLPM dis-
cussed below.
By protein-DNA crosslinking
Hepatitis C Virus Nonstructural Protein 3 (HCV NS3) is a
multifunctional enzyme. Its N-terminal 180-amino acid
region has protease activity and its C-terminal 465-amino
acid region has helicase activity [33,34]. Helicase unwinds
DNA or RNA and is one of the core enzymes required for
replication, transportation and repair, and recombina-
tion. Understanding how the helicase-nucleic acid com-
plex forms is essential for insight into the viral life cycle
and for developing treatment for patients with hepatitis C.
Tackett et al showed that NS3 unwinding activity is sensi-
tive to the structure of the helicase-nucleic acid duplex
[35]. A crystal structure of single-stranded DNA (ssDNA)
bound NS3 helicase domain (NS3h) has been published.
[36] But to our knowledge, no mass spectrometric analy-
sis of the NS3h-ssDNA interaction has been reported. We
combined a photochemical crosslinking approach with
sequential Q-TOF ESI analysis to acquire the data on the
interacting complex. The data were analyzed by CLPM to
map the peptide interacting with the ssDNA, and this
result was validated by analyzing the spatial relationships
within the published crystal structure.
The study was carried out with the crosslinking of NS3h to
a specially-designed DNA 28mer, which contains a 5'-
biotin tag, a '3-fluorescent tag and a UV sensitive bro-
mouridine group in the middle. The biotin tag facilitates
the extraction of the crosslinked peptide after protease
digestion by forming covalent bonds with streptavidin,
which is covalently attached to superparamagnetic poly-
styrene beads. The fluorescent-tag provides an extra
method to confirm the crosslinking of the oligonucleotide
to the target protein and the bromouridine covalently
reacts with oxidizible amino acid sidechains (aromatic or
S-containing) when exposed to UV light with wavelengths
greater than 300 nm while causing minimal photodam-
age to other amino acids. Crosslinking was initiated with
Mechanism of handling modifications Figure 7
Mechanism of handling modifications. (A) For a 
crosslinked peptide with three modifiable sites M1, M2, and 
M3, with 2, 1, and 1 possible types of modifications at each 
site, respectively, CLPM will generate its derivatives. (B) 
Masses are calculated for each possible combination of deriv-
atives. BM represents the basic mass minus the mass of a 
peptide without adding any modifications.
M1 M2
M3
R
K
A
Der1=BM
Der2=BM +
Der3=BM + 
Der4=BM +
Der5=BM +
Der6=BM +
B
Der11=BM +
Der8=BM +
Der12=BM +
Der10=BM +
Der7=BM +
Der9=BM + 
Comparison of the results of uncrosslinked tryptic BSA by  CLPM and MASCOT Figure 8
Comparison of the results of uncrosslinked tryptic 
BSA by CLPM and MASCOT. Peptides in <red> were 
found by MASCOT, while peptides in () were found by 
CLPM. There were 34 peptides found by MASCOT and all 
were included in the 45 peptides found by CLPM. Settings for 
the searches were the same except carbamidmethylation of 
Cys was set as a fixed modification in MASCOT while it was 
a variable modification in CLPM.
1 MKWVTFISLL LLFSSAYSRG VFRRDTHKSE IAHR(<FK(DLGE EHFK)>)(<GLVLIA
51 FSQYLQQCPF DEHVK>)LVNEL TEFAK(<TCVAD ESHAGCEK>)(<SL HTLFGDELCK>)
101 VASLRETYGD MADCCEK(<(<QEP ER(NECFLSHK>)( <DDSPDLPK>))>)(<(<LK (PDPNTLCDEF
151 K)>)(ADEK>)KFWGK) (<YLYEIAR>)RHP YFYAPELLYY ANK(<YNGVFQE CCQAEDK>)GAC
201 LLPK(IETMRE K)VLTSSAR(QR LR(CASIQK)FG ER)ALKAWSVA R(<LSQKFPK>)(<AE
251 FVEVTK>)LVTD LTKVHK((<ECCH GDLLECADDR>) ADLAK)(<YICDN QDTISSK>)(<LK(<E
301 CCDKPLLEK>))>(<S HCIAEVEK>)(<(DA IPENLPPLTA DFAEDK)DVCK>) NYQEAK(<DAFL
351 GSFLYEYSR>)(<R (HPEYAVSVLL R)>)LAK(<EYEATL EECCAK>)(<DDPH ACYSTVFDK>)L
401 KHLVDEPQNL IK(<QNCDQFEK>) LGEYGFQNAL IVRYTR(<K(<VPQ VSTPTLVEVS
451 R>)>)SLGKVGTRC CTKPESERMP CTEDYLSLIL NR(<LCVLHEK>)T PVSEK(VTK(<CC
501 TESLVNR>))(<RPC FSALTPDETY VPK>)AFDEK(<LF TFHADICTLP DTEK>)(QIK(<K(<QT
551 ALVELLK>)>))HKP KATEEQLKTV MENFVAFVDK (<CCAADDKEAC FAVEGPK>)LVV
601 STQTALA BMC Bioinformatics 2005, 6(Suppl 2):S9
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a ratio of NS3h/DNA 3uM/1 uM. After three hours of UV
light excitation, the sample was subjected to fluorescent
image and commassie-stained image analysis to confirm
the crosslinking (Figure 10), gel-cutting and in-gel trypsin
digestion to yield peptide mixtures, extraction to purify
crosslinked peptides, DNase digestion to degrade the
DNA sequence into short remnants and ESI-MS/MS anal-
ysis to acquire the data. The analytic strategy is shown in
Figure 11.
During the analysis with CLPM, crosslinking amino acids
and the mass changes caused by different types of modifi-
cations are defined in CLPM by the ion structures of dinu-
cleotides specified by Golden [31] (Figure 12). The result
Result of assessment of CLPM with a crosslinked sample Figure 9
Result of assessment of CLPM with a crosslinked sample. (A) BS3 was chosen as the crosslinker to crosslink peptide P, 
whose sequence is acetyl-AYAGKAGAR (in 95% purity). In the MS spectrum, precursor peaks of both crosslinked and 
uncrosslinked peptides were seen with different charges. (B) CLPM's output shows that an unacetylated peptide was found to 
match peak 432.7 (2H+) (light blue) and the crosslinked specie of the acetylated peptide was found to match to peak 650.63 
(3H+) (dark blue). The output includes the precursor peak, the peptide sequence, the mass of the peptide, the mass-difference 
between actual and theoretical masses, the modifications (if any), and the possible modified locations.
acetyl-P-BS3-acetyl-P
(1H+)
P4 + BS3
400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
m/z 0
100
%
062304_11_YT3 236 (25.750) AM (Cen,2, 80.00, Ht,5000.0,0.00,1.00); Sm (Mn, 2x3.00); Cm (183:279) 1: TOF MS ES+ 
2.14e4 650.6459
453.7415
531.7300
532.2483
600.7720
978.0135
975.3524 650.9832
715.3726
939.9592
786.4312
1062.4050 1119.3601
1950.9147 1121.3044
1310.5038 1122.2635
1722.8074 1360.6495 1463.5521
1603.8394 1865.9408
1953.0100
acetyl-P-BS3-acetyl-P
(2H+)
acetyl-P-BS3-acetyl-P
(3H+)
acetyl-P
(1H+)
acetyl-P
(2H+)
P(2H+)
modified type:: any_peptide_N-term acetylation
modified AA:: b
modified spot:: 12
modified type:: any_peptide_N-term acetylation
modified AA:: b
modified spot:: 1
the modifications
thoe_act_MsDif:: -63.039511ppm
theoretical mass:: 1949.027558
the sequence is:: AYAGKAGAR*AYAGKAGAR
observed mass:: 1948.904700
observed charge:: 3.000000
observed M/H:: 650.634900
the data from pkl file are 
NO. 1 matched peptide
thoe_act_MsDif:: -18.934617ppm
theoretical mass:: 863.461349
the sequence is:: AYAGKAGAR
observed mass:: 863.445000
observed charge:: 2.000000
observed M/H:: 432.722500
the data from pkl file are 
NO. 2 matched peptide
A
BBMC Bioinformatics 2005, 6(Suppl 2):S9
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indicated that the doubly-charged ion with a mass of
770.8163Da matched to a sequence covering the amino
acid residues of NS3h protein [36] s from 364 to 372
(HLIFCHSK) with the attachment of a dinucleotide,
dGdU, which is considered the "ideal" remnant of deoxy-
oligonucleotide after being digested by DNase I [30,31].
MS spectrum and MS/MS spectrum of this ion are shown
in Figure 13. The cysteine, phenylalanine and two histi-
dines within this peptide can all react with the oligonucle-
otide. By studying the crystal structure of nucleic acid-
bound NS3h, we discerned a very close proximity of H-
369 to the deoxyuridine. (Figure 14)
Discussion
CLPM finds crosslinked peptides derived from crosslink-
ing reactions of one or two known proteins in addition to
identifying uncrosslinked peptides. By treating the cleava-
ble crosslinker or oligonucleotide as a type of modifica-
tion to the peptides, CLPM can also be used to analyze the
MS data of crosslinked peptides with cleavable crosslink-
ers and protein-DNA/protein-RNA heteroconjugates. By
doing in silico digestion and in silico crosslinking, it gener-
ates a peptide pool including both crosslinked and
uncrosslinked peptides. The mass of each peptide will be
compared at least once to the calculated masses of the pre-
cursor peaks.
CLPM determines whether or not a precursor peak
matches a peptide by calculating the mass-difference
between the observed masses and the theoretical masses.
If the mass-difference is within a specified error tolerance,
then the peptide is considered to match the precursor
peak. Starting first with unmodified peptide matches,
CLPM tries to avoid false positive hits with the myriad of
potential derivatives. If an unmodified peptide is found to
be a match with one of the precursor peaks, no further
comparisons will be made with any of the potential mod-
ified peptides. However, if an unmodified peptide can't be
matched to any of the precursor peaks, CLPM will work
with different combinations of modifications until a
mass-difference within the error tolerance is found, if pos-
sible.
In the assessment with an uncrosslinked sample, CLPM
successfully mapped all 34 peptides that were found by
MASCOT. Further analysis of the 11 peptides uniquely
SDS-PAGE analysis of NS3h-deoxynucleotide photocrosslink Figure 10
SDS-PAGE analysis of NS3h-deoxynucleotide photocrosslink. The crosslink reaction was initiated by exposing the 
sample to 305 ± 16 nm UV light for three hours. The concentration of DNA was 1 uM and the NS3h concentration was 3 uM. 
After crosslinking, the sample was separated by SDS-PAGE (12% acrylamide gel). Fluorescent image was taken before (A) and 
after (B) Commassie staining. Horizontal arrows identify the crosslinked proteins that are 10 kDa heavier than uncrosslinked 
proteins. Lanes a and i are molecular markers, b is NS3h without adding deoxynucleotide, and c is NS3h and deoxynucleotide 
without UV light excitation. Lanes d, e, f, and g are NS3h plus deoxynucleotide with three hours activation by 305 nM UV light. 
Lane h was unused and served as a negative control.
B A
a bc d e f g h i a bc d e f g h iBMC Bioinformatics 2005, 6(Suppl 2):S9
Page 9 of 14
(page number not for citation purposes)
found by CLPM showed that the corresponding precursor
peaks were also assigned by MASCOT to other peptides
outside the BSA protein and with insignificant scores. The
accuracy of MASCOT's results could have been impaired
by the low quality of the tandem MS data of those 11 pep-
tides. In other words, the finding of the 11 peptides only
by CLPM but not by MASCOT doesn't necessary imply
that they are false hits. In the assessment of the sample
with a crosslinking reaction, both uncrosslinked and
crosslinked peptides were correctly matched to precursor
peaks. However, we should note that CLPM does not try
to assign each and every observed precursor peak. Rather,
CLPM starts with the theoretical peptides derived from the
known input sequences. In the case of a peptide with sev-
eral possible combinations of modifications, only the one
with a mass-difference which is within the threshold and
is the smallest among all derivates is considered a match.
Experience finds this approach greatly reduces the number
of false positives. This comes with a disadvantage that
only one of several possible peaks which could be
assigned to a peptide will be shown as a match.
In the analysis of the NS3h-DNA photochemical
crosslinked complex, the possible DNA remnants were
treated either as crosslinkers or modifications. In both
cases, the same results were derived from CLPM. This
result was validated by an X-ray diffraction study, where a
very close proximity between H-369 and DNA was shown.
A unique challenge was introduced by the DNA moiety:
even though some oligonucleotide fragmentation rules
under positive-ion mode have been proposed and
approved [30-32], there are still many irregularities (e.g.,
Procedure to study protein-nucleic acid interactions Figure 11
Procedure to study protein-nucleic acid interactions. The oligonucleotide is designed to contain a 5'-biotin tag, a 3'-flu-
orescent tag and a UV sensitive group in the middle. (A) Crosslink initiated by exposing to UV (305+16 nm). (B) After three 
hours of UV activation, denatured samples were subjected to SDS-PAGE analysis, where crosslinked species were confirmed 
by fluorescent imaging and all bands were visualized by Commassie staining technique. (C) Interesting spots were picked for 
protease enzymatic in-gel digestion to yield peptide mixtures. (D) Crosslinked peptides were extracted by magnetic streptavi-
din beads and uncrosslinked peptides were washed away. (E) The crosslinked peptides were subjected to DNase I degradation 
to minimize the attaching oligonucleotide moieties. (F) Crosslinked peptides with the remaining nucleic acid attached were 
extracted by reverse phase ZipTip C18 cartridge and analyzed by Q-tof ESI. (G) Raw data were collected and processed by 
Protein-Lynx to generate a PKL file, which was used as input to CLPM to identify matches with theoretical peptides.
Data analysis
(CLPM)
A B
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D E
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the uncertain number of hydrogen ions maintained by a
phosphate group). This greatly increases the complexity of
the MS/MS spectrum of peptide-DNA heteroconjugate,
which in-turn makes the direct sequence confirmation
very difficult. CLPM requires only MS data instead MS/MS
data as its input. As long as the mass of DNA moiety was
correctly specified, CLPM will map the crosslinked pep-
tide based on its total mass. In the case of uncertain DNA
moiety structures, such as in an uncertain degree of DNase
degradation, all possible moieties could be selected.
CLPM will derive all probable heteroconjugates which can
guide further mutagenesis or other corroboration studies.
MS-based methods continue to be the foundation of pro-
teomic analysis [37]. Several other MS-based algorithms
such as X-Link [38], NIH-XL [39] and FindLink [40] have
been reported to have the abilities to analyze mass spec-
trometric data of crosslinked reactions. Instead of the
best-match approach used in CLPM, X-Link finds all pos-
sible crosslinked species solely based on their masses and
then identifies the correct species by comparing the
expected fragmentation patterns to observed MS/MS data
[38]. Moreover, none are freely and publicly available via
the Web. To our knowledge, no further detail descriptions
of these algorithms have been reported.
As with other MS-based algorithms, the usefulness of
CLPM is dependent upon the accuracy of its input: the
mass changes due to modifications, and the introduction
of crosslinkers, Of course, the inherent accuracy of the
mass spectrometry is also a crucial factor. CLPM uses the
monoisoptopic values of amino acid residues from http:/
/www.ionsource.com/Card/aatable/aatable.htm[41] and
the mass change values due to modifications from http://
www.unimod.org/[42].
Conclusion
With the expanding use of mass spectrometry for protein
studies comes the need for powerful software to analyze
complicated, crosslinked proteins [3]. Identifying pep-
tides by their masses can be an efficient starting point for
direct sequence confirmation. The CLPM algorithm pro-
vides a powerful tool in identifying these potential inter-
action sites in combination with chemical crosslinking
and mass spectrometry. Through this cost-effective
approach, subsequent efforts can quickly focus attention
on investigating these specific interaction sites.
Availability
A free version of CLPM without a graphical interface is
available upon request from Yong Tang
YxTang2@UALR.edu. This software can be installed on
any PC with a minimum requirement of 256 MB RAM. A
web-accessible CLPM is available from the MidSouth Bio-
informatics Center at: http://bioinformatics.ualr.edu/
mbc/services/CLPM.html
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Materials and Methods for HCV NS3 Analysis
The HCV NS3 study was carried out with a specially-
designed deoxy-oligonucleotide which contains a photo-
sensitive bromouridine group in the middle, a 5'-biotin
tag and a 3'-fluorescent tag. The fluorescent tag is 6-car-
boxyfluorescein (6-FAM) which is a single isomer deriva-
tive of fluorescein; it provides an extra method to confirm
the crosslinking of the oligonucleotide to the target pro-
tein. The 5'-biotin tag facilitates the extraction of the
crosslinked peptide after protease digestion by forming
covalent bonds with streptavidin which is covalently
attached to superparamagnetic polystyrene beads. The
bromouridine specifically reacts with oxidizible amino
acid sidechains (aromatic or S-containing) when UV light
with wavelengths greater than 300 nm is applied with
minimum photodamage to certain amino acids. The
experiment is diagrammed in Figure 11.
Materials included in this experiment were:
• Photo-reactive deoxy-oligonucleotides
Possible ion structures for the fragmentation of tryptic pep- tide crosslinked to the dinucleotide (dGdU) after DNase I  digestion as proposed by Golden et al [31] Figure 12
Possible ion structures for the fragmentation of tryp-
tic peptide crosslinked to the dinucleotide (dGdU) 
after DNase I digestion as proposed by Golden et al 
[31]. The blue line on the right of each diagram represents 
the peptide moiety in the heteroconjugate.
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&#x2218; 5'-(Bio)dAdTdG dTdCdG dGdAdT dCdGdC
dAdG/i5Br-dU/ dCdAdG dTdTdT dTdTdT dTdTdT dT(6-
FAM)-3' (stock concentration 144 uM) (synthesized by
Dharmacon).
• Recombinant NS3h stored in HEPES buffer.
• Dynabeads M-280 Streptavidin kit (Dynal Biotech).
Chromatography and Mass spectra of peptide HLIFCHSK crosslinking with dGdU Figure 13
Chromatography and Mass spectra of peptide HLIFCHSK crosslinking with dGdU. (A) Chromatograph shows that 
the peptide eluted at 6.92 minutes. (B) MS spectrum of the crosslinked peptide. CLPM calculated that the doubly-charged pre-
cursor ion 770.808 (2H+) has a mass value of 1539.6326Da, which closely matches this crosslinked peptide whose expected 
mass is 1539.620394Da. The mass difference is 7.93 ppm. The triply-charged ion of this crosslinked peptide can also be found 
at 514.2 (3H+). In the MS/MS spectrum (C), fragmentation led to some b, y-type and internal fragments of the peptide and of 
the nucleic acids that were assigned to some of the peaks as shown.
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• DNase I (Ambion).
• HEPES buffer
&#x2218; 25 mM HEPES pH7.5, 50 mM NaCl, 20% Glyc-
erol, 1 mM EDTA, 2 mM BME
Photo-chemical crosslinking was carried out in 25 mM
HEPES buffer with a final concentration of oligonucle-
otides of 1 uM and NS3h of 3 uM (total volume 100 uL).
Photochemical crosslinking reaction
All reagents were added to a microcentrifuge tube and
gently mixed well. The total 100 uL reagent was split into
80 uL for reaction and 20 uL for Control 1 (which con-
tains both the oligonucleotide and the protein but with-
out UV excitation; Control 2 is a 10 uL 3 uM NS3h
solution without added oligonucleotide). The 80 uL mix-
ture was transferred to a cuvette and placed into the fluor-
ometer for UV excitation with a wavelength setting of 305
nm and a bandpass setting of 16 nm for three hours. The
crosslinking products were added with an equal amount
of protein-loading buffer (PSB+BME) and then denatured
at 100°C for ten minutes.
Visualization of crosslinked species and in-gel digestion
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel
electrophoresis) visualization yielded a fluorescent image
(before Commassie staining) in which free oligonucle-
otides and crosslinked species were identified. The same
gel was subjected to Commassie stain to visualize the
crosslinked and uncrosslinked proteins (Figure 10). Spots
of interest were picked by ProPic (Genomic Solutions
http://www.genomicsolutions.com) and subjected to in-
gel digestion by ProGest (Genomic Solution) (Figure 10).
Four hours of trypsin digestion was performed with a
typsin/protein ratio of 1:20 (wt/wt) with repeating dehy-
dration, rehydration, reduction and alkylation.
Enrichment of crosslinked peptides and degradation of 
oligonucleotides
In order to increase the concentration of peptides, tryptic
samples from spots 1 to 6 were combined together.
Streptavidins were added to the sample with a ratio of 1
mg streptavidin to 200 pm biotinylated single-stranded
oligonucleotide. Uncrosslinked peptides were washed
away, but the crosslinked peptides were kept in the tube
with the use of a magnet. DNase I was then used to
degrade the oligonucleotides with a ratio of 1U DNase I to
1 ug DNA, and the sample was incubated at 37°C in a
HEPES buffer for one hour. The supernatant contains the
photocrosslinked peptides with the majority of the oligo-
nucleotide digested.
Mass spectrometry analysis
The crosslinked peptides with the minimized oligonucle-
otides were extracted with reverse-phase ZipTipC18 (Mil-
lipore) and eluted into an elution buffer (50%
Acetonitrile, 0.1%TFA) for sequential mass spectrometry
analysis. Mass spectrometric data were obtained by Micro-
mass q-TOF Micro spectrometer (Waters) which is con-
nected with a capillary LC system (CapLC, XE, Waters). 20
uL tryptic product was loaded into a ProteoPep C18 col-
umn (New Objective). The flow rate was set to 10 uL per
minute. Solvent B was gradually increased from 5% dur-
ing the first minute to 35% at the nineteenth minute, then
rapidly increased to 90% at minute 22, then retained at
90% until minute 24. Mass spectra (LC/MS) and tandem
mass spectra (LC/MS/MS) were recorded in positive-ion
mode. The peptide precursors were automatically selected
by the instrument and fragmented in a collision cell using
nitrogen as the collision gas and then analyzed by a time-
of-flight (TOF) detector.
Data analyzed by CLPM
Raw data were processed by ProteinLynx to generate a PKL
file. The PKL file was used as input to CLPM. The search
was done with an error tolerance setting of 100 ppm.
Crosslinking amino acids and the mass changes caused by
different types of modifications are defined in CLPM by
the ion structures of dinucleotides specified by Golden
[31] (Figure 12). By comparing this protein-DNA
crosslinking with variable modifications including
The locations of H-369 (yellow) and deoxyuridines (green)  within the NS3h crystal structure are in close proximity Figure 14
The locations of H-369 (yellow) and deoxyuridines 
(green) within the NS3h crystal structure are in close 
proximity. H-369 is located within domain 2, and protrudes 
into the channel where the oligonucleotide binds near the 5' 
end. A peptide (364–372: HLIFCHSK) (red) was identified by 
CLPM as the site of photocrosslinking.BMC Bioinformatics 2005, 6(Suppl 2):S9
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acetylation of a protein's N-terminus, oxidation of Met,
and formation of pyroglutamic acid from N-terminal Glu
and Gln, CLPM performed exhaustive calculations and
comparisons and found the best matches which were
defined to have a minimal mass difference from actual
masses. Further analysis of the LC/MS/MS spectra of those
matched peptides was either done by de novo sequencing
or by searching against Ms2Assign (free, online software
provided by Sandia National laboratories at http://
roswell.ca.sandia.gov/~mmyoung/ms2assign.html[43].
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